Clinical studies recruiting near Rotterdam

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Erasmus Medisch Centrum · Eli Lilly and Company · NCT07218380 PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlus
NA · Erasmus Medical Center · Erasmus Medical Center · NCT05230446 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · Erasmus Medical Center · Leiden University Medical Center · NCT05255653 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Erasmus University Medical Center · Miltenyi Biomedicine GmbH · NCT04844866 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site NL31002 · Astellas Pharma Global Development, Inc. · NCT05970172 The DRAGON 2 Trial
NA · Erasmus Medical Center · Maastricht University · NCT05428735 A Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Stand
Phase N/A · Erasmus University Medical Center Rotterdam, · Promedius Inc · NCT07421713 Screening for Malnutrition in Obese Patients
Phase N/A · ErasmusMC · HAN University of Applied Sciences · NCT06626360 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Erasmus Medisch Centrum-Site Number : 5280001 · Sanofi · NCT07190196 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Sophia Children's Hospital, EMC · The Hospital for Sick Children · NCT06560606 Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Phase 3 · Erasmus Medisch Centrum · Lakefront Biotherapeutics NV · NCT06652633 FCV Vs VCV in Obstructive and Asthmatic Patients
NA · Erasmus Medical Center · Erasmus Medical Center · NCT06563544 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Erasmus Medisch Centrum · Amgen · NCT07037433 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · Erasmus MC · Sint Maartenskliniek · NCT07160231 Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas
Phase N/A · Erasmus MC · Erasmus Medical Center · NCT06180434 Adjuvant Tebentafusp in High Risk Ocular Melanoma
Phase 3 · Erasmus MC · European Organisation for Research and Treatment of Cancer - · NCT06246149 A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · ErasmusMC · Takeda · NCT07244263 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Erasmus MC - Sophia Children's · Children's Hospital of Philadelphia · NCT02708134 Vascular Signature Mapping of Brain Tumor Genotypes
Phase N/A · Erasmus University Medical Center · Leiden University Medical Center · NCT05274919 No Guts No Glory Probiotics
Phase 2/Phase 3 · Antes Parnassia Groep · University Medical Center Groningen · NCT07606014 Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
NA · Franciscus · Medisch Spectrum Twente · NCT07486570 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Diabeter - Rotterdam · Eli Lilly and Company · NCT07222332 Maternal and Fetal/Neonatal Pharmacokinetics and - Dynamics of Corticosteroids During Pregnancy
Phase N/A · Erasmus Medical Center · Erasmus Medical Center · NCT06264973 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · Erasmus Medical Center Rotterdam · Regeneron Pharmaceuticals · NCT05685173 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Erasmus Medisch Centrum · Fore Biotherapeutics · NCT05503797 Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Phase 4 · Erasmus MC · University Hospital, Antwerp · NCT05701241 A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects A
Phase 3 · Erasmus MC, Sophia Kinderziekenhuis · Amicus Therapeutics · NCT04808505 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Erasmus Medisch Centrum · Pfizer · NCT07144280 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Erasmus Medisch Centrum · Eli Lilly and Company · NCT06937086

Look up another city

Look up another condition